PGIM Credit Global Economics Deputy Head Katharine Neiss discusses the Federal Reserve's decision to leave interest rates unchanged on Wednesday, saying Chairman Kevin Warsh delivered a "weaker press conference than expected." Speaking on Bloomberg Television, Neiss adds that the central bank's "Hawkish tilt" will come in September, with three sequential rate hikes.
Lloyds Banking Group Chief Executive Officer Charlie Nunn speaks on Bloomberg Television after the lender's second-quarter earnings beat estimates and the bank unveiled a blueprint to help boost non-banking revenues by 2030. "We've got some exciting growth to do," Nunn says.
Anna Edwards, Guy Johnson and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."
Anglo American Chief Executive Officer Duncan Wanblad discusses the company's performance after it posted a jump in profit and raised its dividend. Speaking on Bloomberg Television, he says the strength in Anglo American's performance has been "bolstered by higher copper price."
Microsoft shares surged in late trading after better-than-expected 4Q earnings, helped by continued strength in cloud computing and artificial intelligence. But Meta shares fell after a disappointing revenue forecast for the current quarter. It also reported the lowest free cash flow in years, a sign of ballooning AI spending. Josh Gilbert, APAC & Middle East Lead Analyst at etoro spoke to Bloomberg's Abeer Abu Omar on Horizons Middle East & Africa on some of the mag7 reporting.
Energy One (ASX:EOL) unanimously rejected an unsolicited all-cash acquisition proposal from Volue AS valued at $17 per share.
Shell Chief Executive Officer Wael Sawan says the company is "built to be able to handle volatility." He adds that Shell also had record utilization in its refining business. "We haven't seen that in over a decade," Sawan tells Bloomberg Television as the company said adjusted net income rose to $9.8 billion.
Paradigm Biopharmaceuticals (ASX:PAR) completed patient enrolment in its global Phase 3 study of Zilosul for knee osteoarthritis pain.
Dr Reddy's CEO Erez Israeli expects a healthy performance in the second half of FY2026-27 once the company resolves the semaglutide issue. Israeli believes the generics market for semaglutide in will be ultra-competitive, with more than 20 companies trying to gain market share.
ADNOC Drilling reported profit for the second quarter that beat estimates. Profits rose 1.7% Y/Y to $357.1 million while revenue grew by 2.9%. Abdulla Ateya Al Messabi, ADNOC Drilling's CEO spoke to Bloomberg's Abeer Abu Omar on the performance as well as future plans for the company.
EBR Systems (ASX:EBR) reported 46 commercial implants for Q2 2026 and preliminary revenue of US$2.6M to US$3M.
The CEO of Schneider Electric says the strategy is to grow organically as much as possible, but could also find new tech companies to accelerate the expansion strategy. Olivier Blum also sees fast growth in data centers in China. He spoke exclusively with Bloomberg's Lizzy Burden from Paris.
